Related Experiment Video
Updated: Jul 18, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
A role for procarboxypepidase U (TAFI) in thrombosis
Johan L Willemse1, Dirk F Hendriks
1Laboratory of Medical Biochemistry, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.
Imbalances in the procarboxypeptidase U (proCPU) system disrupt normal hemostasis, increasing thrombosis risk. Inhibiting CPU may offer new therapeutic strategies for fibrinolytic therapy.
Area of Science:
- Biochemistry
- Hematology
- Physiology
Background:
- Hemostasis relies on the balance between coagulation and fibrinolysis.
- Imbalances in this equilibrium can lead to bleeding or thrombosis.
- Procarboxypeptidase U (proCPU) is a key regulator linking coagulation and fibrinolysis.
Purpose of the Study:
- To review the role of the proCPU/CPU system in hemostasis.
- To discuss how dysregulation of proCPU/CPU contributes to thrombotic tendencies.
- To explore CPU inhibition as a potential therapeutic target for fibrinolytic therapy.
Main Methods:
- Literature review focusing on the proCPU/CPU system.
- Analysis of the molecular mechanisms of CPU in fibrinolysis.
- Review of current research on CPU inhibitors for therapeutic applications.
Main Results:
- Activated CPU (carboxypeptidase U) inhibits fibrinolysis by affecting plasminogen activation.
- A disturbed proCPU/CPU system is associated with an increased risk of thrombosis.
- CPU inhibition presents a promising avenue for enhancing fibrinolytic therapy.
Conclusions:
- The proCPU/CPU system is critical for maintaining hemostatic balance.
- Dysfunction of this system contributes to pathological thrombosis.
- Targeting CPU with inhibitors offers a novel strategy for treating thrombotic disorders.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis III: Interprofessional Care
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

